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SS21.
Mechanochemical Ablation (MOCA) of the Great Sa-
phenous Vein: Two-Year Results and Recommenda-
tions from the Initial Human Trial
Steve Elias. Columbia University and Medical Center,
Englewood, NJ
Objectives: The mechanochemical ablation catheter uti-
lizes a liquid sclerosant (sodium tetradecyl sulfate or aethox-
ysclerol) and a mechanical rotating wire to accomplish occlu-
sion of incompetent GSV or SSV. The procedure does not
require tumescence and is performed with local anesthesia at
the access site only. It can be characterized as mechanically
enhanced sclerotherapy performed in an office setting.
Methods: 30 GSVs in 29 patients underwent mi-
cropuncture access with local anesthesia only in this first in
man study.Through a5Fr.micropuncture sheath theMOCA
catheter was passed to a position 2 cms. from the saphe-
nofemoral junction. Catheter wire rotation was begun for 3
seconds at 3500 rpm. With the wire rotating, infusion of
sclerosant (1.5% sodium tetradecyl sulfate) and catheter pull-
back (1.5 mm./sec) was begun simultaneously. A total of 12
cc. of sclerosant was used for each GSV. The procedure
doesnot require the instillation of tumescent anesthesia.
Results: At 1 year 29 of 30GSVwere successfully treated.
Primaryclosure rate96.7%.At2years24patientswereexamined.
All 24 remain closed. No DVT, nerve or skin injury occurred.
Average total procedure time was 14 minutes. Catheter treat-
ment timewas 5minutes.TheMOCA technique has beenmod-
ified; lower volumes are nowused based on diameter and length
of vein treated. Catheter placement is closer to SFJ (1 cm.).
Conclusions: MOCA is as efficacious at 2 years as cur-
rent endothermal techniques without the need of tumescent
anesthesia and more effective than reported results of foam
sclerotherapy of theGSV. It is another alternativemodality for
most incompetent GSVs and SSVs.
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SS22.
See One, Sim One, Do One, Teach One: Results of a
Prospective Randomized Trial of Endovascular Skills
Training for Surgical Residents
Jason T. Lee, Amy Peruzzaro, Thomas Krummel, Ronald
L. Dalman. Division of Vascular Surgery, Stanford Univer-
sity Medical Center, Stanford, CA
Objectives: Surgical simulation has emerged as an impor-
tant adjunct to residency training in the era of duty-hour work
restrictions. We conducted a prospective randomized trial to
determinewhetheranendovascular simulation-basedcurriculum
improves the technical performance of surgical residents.
Methods: Third year residents rotating on vascular
surgery were randomized to SIMULATION consisting of
weekly faculty-mentored simulation-based sessions and
compared to CONTROL without simulation. Endovascu-
lar skills were assessed pre- and post-rotation on a high-
fidelity simulator utilizing a previously validated endovas-
cular global assessment scale (score 1-5), and a live OR
patient evaluation at the end of the rotation.
Results: From 2008-2011, 25 consecutive surgical resi-
dents (13 SIMULATION, 12 CONTROL) rotating on a uni-
versity VS service were enrolled. PRE-test assessment was not
differentbetweengroupsdocumenting similarbaseline skills (1.6
vs. 1.4), andoperative exposureduring their 8-week rotationwas
similar foropenandendovascular cases.Amountof time reading,
didactic teaching, and conference attendance was also similar
between cohorts. There was significant improvement on the
POST-test (3.6 vs. 1.5) assessed on the simulator for the entire
group, with the residents assigned to the SIMULATIONgroup
outperforming the CONTROL group (4.0 vs. 3.3) on the sim-
ulator and in the live patient OR assessment (3.5 vs. 2.5).
Conclusions: Implementation of an intensive simulation-
based endovascular curriculum during the VS rotationimproved
the technical skill of surgical residentsonahigh-fidelity simulator,
and translated to improved live OR performance beyond the
usual teaching obtained from standard clinical rotations.
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SS23.
Outcomes Comparison of HeRO and Lower-Extremity
Arteriovenous Graft in Patients with Long-Standing
Renal Failure
Samuel N. Steerman, Jason Wagner, Jonathan A. Higgins,
Claudia Kim, Aleem Mirza, James Pavela, Jean M. Pan-
neton, Marc Glickman. Eastern Virginia Medical School,
Norfolk, VA
Objectives: The HeRO (Hemodialysis Reliable Out-
flow) graft is becoming a recognized alternative to
Lower Extremity AV Grafts (LEAVG) as an option for
patients who have exhausted traditional upper extremity
access; however it is unclear which should be applied
preferentially.
Methods: A retrospective review of LEAVG and
HeRO implants from January 2006 to August 2010 was
performed. Patient demographics, medical history, proce-
dural data and outcomes were evaluated.
Results: Within the time periods, 62 HeRO’s were
placed in 61 patients and 23 LEAVG were placed in 21
patients. Demographics were similar between the two
groups for gender, age, BMI, and race. Average fol-
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